Fibroblast Growth Factor 2 (Basic) (FGF2) (C-Term part) Antikörper

Antigen: Fibroblast Growth Factor 2 (Basic) (FGF2)

Synonyme: BFGF, FGFB, HBGF-2, bFGF, Fgf-2, FGF2, nudt6, fgf2, MGC52602, FGF-2, bfgf, fgfb, fgf-2, xfgf2, hbgh-2, HBGF2, LOC100227798, Fgfb

Epitope: C-Term part

Klonalität: Polyklonal

Wirt: Schaf

Applikation: Immunhistochemie (IHC), Western Blot (WB)

Produktnummer: ABIN350321

Produktbeschreibung

Weitere Bezeichnung: fibroblast growth factor 2 (FGF2) (c-terminal part)

Swiss-Prot: P09038

Immunogen: A synthetic peptide as a part of human, mouse, rat, guinea pig and rabbit basic FGF (FGF2) conjugated to an immunogenic carrier protein was used as the immunogen.

Format: Lyophilized

Beschreibung: The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members bind heparin and possess broad mitogenic and angiogenic activities. This protein has been implicated in diverse biological processes, such as limb and nervous system development, wound healing, and tumor growth. The mRNA for this gene contains multiple polyadenylation sites, and is alternatively translated from non-AUG (CUG) and AUG initiation codons, resulting in five different isoforms with distinct properties. The CUG-initiated isoforms are localized in the nucleus and are responsible for the intracrine effect, whereas, the AUG-initiated form is mostly cytosolic and is responsible for the paracrine and autocrine effects of this FGF. Also known as: BFGF, FGFB, HBGF-2, prostatropin.

Spezifität: Appears to be specific for FGF2.

Anwendungen

Applikationshinweise: IHC, WB. A dilution of 1 : 300 to 1 : 4000 is recommended. The optimal dilution should be determined by the end user.

Reinheit: whole serum

Lagerung: Maintain the lyophilised/reconstituted antibodies frozen at -20°C for long term storage and refrigerated at 2-8°C for a shorter term. When reconstituting, glycerol (1:1) may be added for an additional stability. Avoid freeze and thaw cycles.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Publikationen

Publikationen: Watson, Anthony, Pickett et al.: "Reverse transcription with nested polymerase chain reaction shows expression of basic fibroblast growth factor transcripts in human granulosa and cumulus cells from in vitro fertilisation patients." in: Biochemical and biophysical research communications, Vol. 187, Issue 3, pp. 1227-31, 1992 (PubMed).

Zhu, Komiya, Chirino et al.: "Three-dimensional structures of acidic and basic fibroblast growth factors." in: Science (New York, N.Y.), Vol. 251, Issue 4989, pp. 90-3, 1991 (PubMed).

Ago, Kitagawa, Fujishima et al.: "Crystal structure of basic fibroblast growth factor at 1.6 A resolution." in: Journal of biochemistry, Vol. 110, Issue 3, pp. 360-3, 1992 (PubMed).

Prats, Kaghad, Prats et al.: "High molecular mass forms of basic fibroblast growth factor are initiated by alternative CUG codons." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 86, Issue 6, pp. 1836-40, 1989 (PubMed).

Arkudas, Tjiawi, Bleiziffer et al.: "Fibrin gel-immobilized VEGF and bFGF efficiently stimulate angiogenesis in the AV loop model." in: Molecular medicine (Cambridge, Mass.), Vol. 13, Issue 9-10, pp. 480-7, 2007 (PubMed).

Neuzil, Swettenham, Wang et al.: "alpha-Tocopheryl succinate inhibits angiogenesis by disrupting paracrine FGF2 signalling." in: FEBS letters, Vol. 581, Issue 24, pp. 4611-5, 2007 (PubMed).

Alexander, Watt, Sawaji et al.: "Activin A is an anticatabolic autocrine cytokine in articular cartilage whose production is controlled by fibroblast growth factor 2 and NF-kappaB." in: Arthritis and rheumatism, Vol. 56, Issue 11, pp. 3715-25, 2007 (PubMed).